Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casey Liveringhouse

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|July 2, 2021
Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancerCasey Liveringhouse, Austin Sim, Kosj Yamoah, et al.
Advances in Radiation Oncology|March 18, 2024
Novel Postoperative Hypofractionated Accelerated Radiation Dose-Painting Approach for Soft Tissue SarcomaMatthew Mills, Justin Miller, Casey Liveringhouse, et al.
Advances in Radiation Oncology|May 23, 2024
Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue SarcomasJohn Michael Bryant, Matthew N Mills, George Q Yang, et al.
Advances in Radiation Oncology|November 24, 2022
Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART)J M Bryant, Russell F Palm, Casey Liveringhouse, et al.
International Journal of Breast Cancer|July 10, 2018
Personalizing Radiation Treatment Delivery in the Management of Breast CancerKamran A Ahmed, G Daniel Grass, Amber G Orman, et al.
Journal of Geriatric Oncology|August 30, 2020
The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomesMatthew Mills, Casey Liveringhouse, Frank Lee, et al.
Clinical Lung Cancer|May 8, 2024
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy AloneMatthew N Mills, Akihiro Uno, Pinxue Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2024
Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcomaJohn Michael Bryant, Matthew N Mills, Casey Liveringhouse, et al.
Advances in Radiation Oncology|December 4, 2023
Trimodal Therapy Using an MR-guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder CancerCasey Liveringhouse, Alexander Netzley, John M Bryant, et al.
Communications Medicine|May 22, 2024
Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesionsJ M Bryant, Ruben J Cruz-Chamorro, Alberic Gan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|July 2, 2021
Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancerCasey Liveringhouse, Austin Sim, Kosj Yamoah, et al.
Advances in Radiation Oncology|March 18, 2024
Novel Postoperative Hypofractionated Accelerated Radiation Dose-Painting Approach for Soft Tissue SarcomaMatthew Mills, Justin Miller, Casey Liveringhouse, et al.
Advances in Radiation Oncology|May 23, 2024
Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue SarcomasJohn Michael Bryant, Matthew N Mills, George Q Yang, et al.
Advances in Radiation Oncology|November 24, 2022
Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART)J M Bryant, Russell F Palm, Casey Liveringhouse, et al.
International Journal of Breast Cancer|July 10, 2018
Personalizing Radiation Treatment Delivery in the Management of Breast CancerKamran A Ahmed, G Daniel Grass, Amber G Orman, et al.
Journal of Geriatric Oncology|August 30, 2020
The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomesMatthew Mills, Casey Liveringhouse, Frank Lee, et al.
Clinical Lung Cancer|May 8, 2024
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy AloneMatthew N Mills, Akihiro Uno, Pinxue Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2024
Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcomaJohn Michael Bryant, Matthew N Mills, Casey Liveringhouse, et al.
Advances in Radiation Oncology|December 4, 2023
Trimodal Therapy Using an MR-guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder CancerCasey Liveringhouse, Alexander Netzley, John M Bryant, et al.
Communications Medicine|May 22, 2024
Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesionsJ M Bryant, Ruben J Cruz-Chamorro, Alberic Gan, et al.
Pageof 2